ID: ALA3594290

Max Phase: Preclinical

Molecular Formula: C17H24Cl2O4

Molecular Weight: 363.28

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCCCCCCC(=O)c1c(OC)c(Cl)c(OC)c(Cl)c1OC

Standard InChI:  InChI=1S/C17H24Cl2O4/c1-5-6-7-8-9-10-11(20)12-15(21-2)13(18)17(23-4)14(19)16(12)22-3/h5-10H2,1-4H3

Standard InChI Key:  HDPLIRGRDMNJKR-UHFFFAOYSA-N

Associated Targets(non-human)

Drosophila (190 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 363.28Molecular Weight (Monoisotopic): 362.1052AlogP: 5.56#Rotatable Bonds: 10
Polar Surface Area: 44.76Molecular Species: NEUTRALHBA: 4HBD: 0
#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): 0#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: CX LogP: 5.19CX LogD: 5.19
Aromatic Rings: 1Heavy Atoms: 23QED Weighted: 0.40Np Likeness Score: 0.47

References

1. Nguyen VH, Kikuchi H, Kubohara Y, Takahashi K, Katou Y, Oshima Y..  (2015)  Development of novel DIF-1 derivatives that selectively suppress innate immune responses.,  23  (15): [PMID:26122773] [10.1016/j.bmc.2015.06.027]

Source